Corporate Banner
Satellite Banner
Stem Cells, Cellular Therapy & Biobanking
>
Scientific Community
 
Become a Member | Sign in
Home>News>This Article
  News
Return

Oxford Optronix Launches HypoxyLab™

Published: Thursday, November 14, 2013
Last Updated: Thursday, November 14, 2013
Bookmark and Share
HypoxyLab™ provides a physiologically reproducible, contamination-free, low oxygen/hypoxia environment to create optimal conditions for life science and clinical medicine research.

Oxford Optronix has announced the formal launch of HypoxyLab™ - the industry’s first benchtop, HEPA-filtered, precision-controlled hypoxia workstation.

HypoxyLab creates optimal, contamination-free conditions for a wide variety of cell-based research fields, including cancer biology, radiation cell biology, cardiovascular research, apoptosis, neurology, stem cell research, multidisciplinary drug development and proteomics.

HypoxyLab is a unique, fully-featured and easy-to-use hypoxia workstation that accurately reproduces physiological conditions for cell-based research.

HypoxyLab provides a highly stable, localized environment in which levels of oxygen, carbon dioxide, temperature and humidity are precisely controlled within a HEPA-filtered isolation work chamber.

Using the optional OxyLite™ module, HypoxyLab also uniquely offers support for direct oxygen partial pressure (pO2) measurements from cell media or tissue using fibre-optic sensors.

The ergonomically-designed benchtop workstation maintains ultra-stable climatic conditions using processor-controlled temperature and the latest nebulizer-based, humidifier technology - delivering requisite levels of humidity whilst maintaining a Class 5 environment.

Precision concentrations of O2 and CO2 as well as chamber temperature and humidity are controlled via a color touch-screen display and delivered using unique, electronic gas flow controllers and auto-calibrating, sensors.

The workstation displays real-time values of chamber O2, CO2, Temperature and Humidity on the touch-screen and simultaneously records this information onto a USB memory stick for off-line analysis.

HypoxyLab’s highly optimized working volume ensures ultra-rapid cell cycling and tissue response times, whilst precise oxygen profiling and cycling is controlled via the intuitive graphical user interface. This allows researchers to easily create any number of bespoke oxygen profiling patterns.

In tissue culture technology, there is a growing need for systems capable of creating precise and reproducible mammalian cell environments - now recognized as vital for accurate analysis of both cell metabolism and cell function.

However, a significant proportion of cell biology research is still performed in ‘traditional incubators’, in which cells are routinely exposed to the oxygen values found in air - at least two or three times the value expected in normal tissues - leading to cellular stress, significant physiological changes which influence differentiation, growth factor signaling and other cellular processes including post-translational metabolic pathways.

By delivering a contamination-free environment that offers precise and continuous control of O2, CO2, temperature and humidity, Oxford Optronix’s new HypoxyLab workstation delivers a powerful new solution to research teams looking to accurately reproduce real-life physiological conditions in cell-based research.

Commenting on the launch, Andy Obeid PhD, CEO of Oxford Optronix said: “With the growing industry-wide recognition of the need to create physiologically reproducible, low oxygen and hypoxic environments for mammalian cells in the laboratory, we were determined to create a solution for our customers that combines cost-effectiveness and a small form factor with unrivalled accuracy and precision. Our new HypoxyLab is easy to use, economic to run and delivers the industry’s first benchtop, HEPA-filtered hypoxia workstation with applicability for every cell-based research laboratory.”


Further Information
Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 2,500+ scientific posters on ePosters
  • More than 3,700+ scientific videos on LabTube
  • 35 community eNewsletters


Sign In



Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into TechnologyNetworks.com you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.


Scientific News
The Mending Tissue - Cellular Instructions for Tissue Repair
NUS-led collaborative study identifies universal mechanism that explains how tissue shape regulates physiological processes such as wound healing and embryo development.
Tissue Bank Pays Dividends for Brain Cancer Research
Checking what’s in the bank – the Brisbane Breast Bank, that is – has paid dividends for UQ cancer researchers.
iPS Cells Discover Drug Target for Muscle Disease
Researchers have designed a model that reprograms fibroblasts to the early stages of their differentiation into intact muscle cells in a step towards a therapeutic for Duchenne muscular dystrophy.
Engineered Hot Fat Implants Reduce Weight Gain
Scientists at UC Berkeley have developed a novel way to engineer the growth and expansion of energy-burning “good” fat, and then found that this fat helped reduce weight gain and lower blood glucose levels in mice.
Transplanted Stem Cells Can Benefit Retinal Disease Sufferers
Tests on animal models show that MSCs secrete growth factors that suppress causes of diabetic retinopathy and macular degeneration.
MRI Scanners Can Steer Therapeutics to Specific Target Sites
Scientists from the University of Sheffield have discovered MRI scanners, normally used to produce images, can steer cell-based, tumour busting therapies to specific target sites in the body.
Team Finds Early Inflammatory Response Paralyzes T Cells
Findings could have enormous implications for immunotherapy, autoimmune disorders, transplants and other aspects of immunity.
Early Detection of Lung Cancer
The University of Manchester has signed a collaboration agreement with Abcodia to perform proteomics studies on a cohort of non-small cell lung cancer cases from the UKCTOCS biobank, with the aim of discovering new blood-based biomarkers for earlier detection of the disease.
Researchers Identify Drug Candidate for Skin, Hair Regeneration
Formerly undiscovered role of protein may lead to the development of new medications that stimulate hair and skin regeneration in trauma or burn victims.
Basis for New Treatment Options for a Fatal Leukemia in Children Revealed
Detailed molecular analyses allow new insights into the function of tumour cells and options for new treatments.
Skyscraper Banner

Skyscraper Banner
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
2,500+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
3,700+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FREE!